摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3,5,7-Tetraazphenanthren | 60072-12-0

中文名称
——
中文别名
——
英文名称
1,3,5,7-Tetraazphenanthren
英文别名
pyrimido[4,5-f]quinazoline;Pyrimidoquinazoline;pyrimido[4,5-f]quinazoline
1,3,5,7-Tetraazphenanthren化学式
CAS
60072-12-0
化学式
C10H6N4
mdl
——
分子量
182.184
InChiKey
XPBSKOLNCVNFGD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    14
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    51.6
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • [EN] HYPOXIA-INDUCIBLE FACTOR 1 (HIF-1) INHIBITORS<br/>[FR] INHIBITEURS DU FACTEUR HIF-1 INDUIT PAR L'HYPOXIE
    申请人:US HEALTH
    公开号:WO2016164412A1
    公开(公告)日:2016-10-13
    Embodiments of small molecule inhibitors of hypoxia inducible factor 1 (HIF-1) and pharmaceutical compositions thereof are disclosed. The disclosed compounds suppress HIF-1 activity by inhibiting the interaction between the HIF- 1 α subunit and transcriptional co-activator protein p300. Embodiments of methods for making and using the small molecule inhibitors are also disclosed.
    本文披露了针对缺氧诱导因子1(HIF-1)的小分子抑制剂及其药物组合物的实施方式。所披露的化合物通过抑制HIF-1α亚单位与转录共激活蛋白p300之间的相互作用来抑制HIF-1活性。还披露了制备和使用小分子抑制剂的方法的实施方式。
  • [EN] INHIBITORS OF α-AMINO-β-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE<br/>[FR] INHIBITEURS DE LA SEMIALDÉHYDE DÉCARBOXYLASE DE L'ACIDE ALPHA-AMINO-BÊTA-CARBOXYMUCONIQUE
    申请人:TES PHARMA S R L
    公开号:WO2016030534A1
    公开(公告)日:2016-03-03
    The present disclosure discloses compounds capable of modulating the activity of α-amino-β-carboxymuconic acid semialdehyde decarboxylase (ACMSD), which are useful for the prevention and/or the treatment of diseases and disorders associated with defects in NAD+ biosynthesis, e.g., metabolic disorders, neurodegenerative diseases, chronic inflammatory diseases, kidney diseases, and diseases associated with ageing. The present application also discloses pharmaceutical compositions comprising said compounds and the use of such compounds as a medicament.
    本公开揭示了能够调节α-基-β-羧基黄酮酸半醛脱羧酶(ACMSD)活性的化合物,这些化合物对于预防和/或治疗与NAD+生物合成缺陷相关的疾病和紊乱非常有用,例如代谢紊乱、神经退行性疾病、慢性炎症性疾病、肾脏疾病以及与衰老相关的疾病。本申请还揭示了包含所述化合物的药物组合物以及将这些化合物用作药物的用途。
  • PYRIMIDOQUINAZOLINE PIGMENT, METHOD FOR MANUFACTURING PYRIMIDOQUINAZOLINE PIGMENT, AND PIGMENT COLORANT
    申请人:DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD.
    公开号:US20190233649A1
    公开(公告)日:2019-08-01
    The present invention provides a pyrimidoquinazoline pigment having a novel pyrimidine skeleton, the pyrimidoquinazoline pigment having excellent pigment properties, such as coloring power and durability, and excellent infrared reflectivity and a method for producing the pyrimidoquinazoline pigment, and a pigment colorant using the pyrimidoquinazoline pigment. The present invention relates to a pyrimidoquinazoline pigment represented by the following formula (1), wherein R 1 and R 2 each independently represent a benzene ring or a naphthalene ring optionally having a substituent, and a method for producing the pyrimidoquinazoline pigment. In addition, the present invention relates to a pigment colorant containing the pyrimidoquinazoline pigment.
    本发明提供了一种具有新型嘧啶骨架的嘧啶喹啉颜料,该嘧啶喹啉颜料具有优异的颜料性能,如着色力和耐久性,以及优异的红外反射性能,以及一种生产该嘧啶喹啉颜料的方法,以及使用该嘧啶喹啉颜料颜料着色剂。本发明涉及以下式(1)所代表的嘧啶喹啉颜料,其中R1和R2分别独立地表示具有取代基的苯环或环,以及生产该嘧啶喹啉颜料的方法。此外,本发明还涉及包含该嘧啶喹啉颜料颜料着色剂
  • POLYCYCLIC RING-FUSED COMPOUND AND ORGANIC THIN FILM TRANSISTOR UTILIZING SAME
    申请人:Sunagawa Misa
    公开号:US20120273770A1
    公开(公告)日:2012-11-01
    A compound for an organic thin film transistor represented by the following formula (1):
    由以下公式(1)表示的有机薄膜晶体管的化合物:
  • Organic Electronic Device Comprising an Organic Semiconducting Material
    申请人:Lux Andrea
    公开号:US20120283437A1
    公开(公告)日:2012-11-08
    The present invention relates to an organic electronic device comprising an organic semiconducting material comprising at least one compound according to the formulae (I) to (II).
    本发明涉及一种有机电子器件,包括至少一种化合物,其符合式(I)至(II)中的至少一种,其中所述有机半导体材料包括所述化合物。
查看更多